Peripheral nerve block anaesthesia and postoperative pain in acute ankle fracture surgery: the AnAnkle randomised trial
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2021;9(13):8 Br J Anaesth. 2021 Apr;126(4): 881-888.What this means for my practice?
The results of this study suggest that a peripheral nerve blockade, via a popliteal sciatic nerve block and a saphenous nerve block, can significantly reduce post-operative pain and morphine consumption, as well as the incidence of opioid adverse events on post-operative day 2, compared to spinal anesthesia in patients undergoing acute ankle fracture surgery. The analgesic benefit appears to greater in older patients, and this should be explored in future studies. This study was limited by the lack of blinding and differences in initial post-operative care.
Study Summary
One hundred and fifty patients scheduled for an acute ankle fracture surgery were randomized to receive peripheral nerve blockade (popliteal sciatic nerve block; saphenous nerve block; n=77) or spinal anesthesia (n=73). The primary outcome of interest was post-operative pain measured using the Pain Intensity and Opioid Consumption (PIOC) score, a composite of Numeric Pain Rating (NRS) area under the curve pain score and total morphine consumption. Secondary outcomes of interest included NRS area under the curve, morphine consumption, quality of recovery (QoR-15) score, opioid adverse events on the opioid related symptom distress score (OR-SDS), number of patients at risk of post-operative pain, patient satisfaction, and adverse events. Outcomes were assessed up to 27 hours post-operation. Results revealed significantly lower PIOC scores, morphine consumption, and NRS area under curve pain scores in the peripheral nerve block group compared to the spinal anesthesia group (p<0.05 for all). Moreover, the incidence of opioid adverse events on post-operative day 2 and the number of patients at risk of post-operative pain were significantly lower in the peripheral nerve block group (p=0.001). No significant differences in the incidence of adverse events were observed between the two groups (p=0.075).
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!